다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Hillstream BioPharma Inc (HILS)
Hillstream BioPharma Inc (HILS) 뉴스

HILS

Hillstream BioPharma (HILS)

Hillstream BioPharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:HILS

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/03/23	00:12	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:HILS	Hillstream BioPharma Inc
2024/03/23	00:08	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:HILS	Hillstream BioPharma Inc
2024/03/22	06:27	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:HILS	Hillstream BioPharma Inc
2024/03/22	06:25	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:HILS	Hillstream BioPharma Inc
2023/09/26	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HILS	Hillstream BioPharma Inc
2023/09/21	22:35	GlobeNewswire Inc.	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference	NASDAQ:HILS	Hillstream BioPharma Inc
2023/09/12	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HILS	Hillstream BioPharma Inc
2023/09/12	00:51	GlobeNewswire Inc.	Hillstream Enters into an Exclusive Option Agreement to Acquire a Clinical Stage Asset for Chronic Pruritis	NASDAQ:HILS	Hillstream BioPharma Inc
2023/09/09	03:30	GlobeNewswire Inc.	Hillstream BioPharma to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13	NASDAQ:HILS	Hillstream BioPharma Inc
2023/08/31	06:22	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:HILS	Hillstream BioPharma Inc
2023/08/31	06:20	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:HILS	Hillstream BioPharma Inc
2023/08/19	06:15	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:HILS	Hillstream BioPharma Inc
2023/08/12	05:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HILS	Hillstream BioPharma Inc
2023/08/09	21:47	GlobeNewswire Inc.	Hillstream BioPharma to Present at the Sidoti Micro-Cap Virtual Conference on August 16-17, 2023	NASDAQ:HILS	Hillstream BioPharma Inc
2023/07/20	21:00	GlobeNewswire Inc.	Hillstream Advances Next-Gen Multispecific Antibodies for Solid Tumors with Lead HER2/HER3 Program, HSB-3215	NASDAQ:HILS	Hillstream BioPharma Inc
2023/07/18	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HILS	Hillstream BioPharma Inc
2023/07/12	06:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HILS	Hillstream BioPharma Inc
2023/07/10	21:47	GlobeNewswire Inc.	Hillstream BioPharma Announces Strategic Reprioritization of Pipeline to Targeting HER2/HER3 Solid Tumors via Bispecific and ADC Antibodies and Biologics	NASDAQ:HILS	Hillstream BioPharma Inc
2023/07/06	21:30	GlobeNewswire Inc.	Hillstream BioPharma Licenses Technology to Develop Proprietary HER2 and HER3 Antibody Drug Conjugates against Drug-Resistant Breast, Lung, Gastric, and Ovarian Cancers	NASDAQ:HILS	Hillstream BioPharma Inc
2023/06/21	05:55	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:HILS	Hillstream BioPharma Inc
2023/06/17	05:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/22	19:01	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/22	19:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/22	19:01	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/17	05:16	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/16	05:23	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/16	05:21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/15	21:47	GlobeNewswire Inc.	Hillstream BioPharma Strengthens its Board of Directors with Appointment of Kelly Anderson	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/03	05:05	GlobeNewswire Inc.	Hillstream BioPharma Announces Closing of Public Offering of Common Stock	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/02	21:47	GlobeNewswire Inc.	Hillstream BioPharma to Present at Upcoming May 2023 Investor and Industry Conferences	NASDAQ:HILS	Hillstream BioPharma Inc

검색 관련기사 보기:NASDAQ:HILS

1 2 3 다음 >>

Casam Etf CD8 Inav

Innovative Financial and...

Republic of France 0.100...

British Controlled Oilfi...

Terra Luna Classic

Vontobel Financial Produ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관